JRCT ID: jRCTs031180292
Registered date:15/03/2019
Fibrinolytic therapy with urokinase
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Refractory intrathoracic infection |
Date of first enrollment | 19/10/2018 |
Target sample size | 30 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Intrapleural injection of 60,000 to 120,000 units of urokinase per day. Injection 1 to 3 days. |
Outcome(s)
Primary Outcome | Ratio of patients that were cured without surgical intervention during hospitalization |
---|---|
Secondary Outcome | Ratio of serious adverse events |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1.Patient with refractory intrathoracic infection 2. Patient with thoracic drain 3. Hospitalized patient 4. Patient with consent |
Exclude criteria | 1.Patient with active intrathoracic bleeding 2. Patients considered unfit to participate by a doctor |
Related Information
Primary Sponsor | Yajima Toshiki |
---|---|
Secondary Sponsor | Yajima Toshiki |
Source(s) of Monetary Support | |
Secondary ID(s) | UMIN000031102 |
Contact
Public contact | |
Name | Seshiru Nakazawa |
Address | 3-39-15 Showa-machi, Maebashi, Gunma,JAPAN Gunma Japan 371-8511 |
Telephone | +81-27-220-8224 |
snakazawa@gunma-u.ac.jp | |
Affiliation | Gunma University Hospital |
Scientific contact | |
Name | Toshiki Yajima |
Address | 3-39-15 Showa-machi, Maebashi, Gunma,JAPAN Gunma Japan 371-8511 |
Telephone | +81-27-220-8224 |
yajimato@gunma-u.ac.jp | |
Affiliation | Gunma University Hospital |